Stem therapy to treat multiple sclerosis may benefit greatly from a new study published in Proceedings of the National Academy of Sciences by the laboratory of Fraser Sim, Ph.D., assistant professor of Pharmacology and Toxicology at University of Buffalo’s School of Medicine and Biomedical Sciences. Dr.
myelin
Recommended Posts
- Common fever meds may ease MS fatigue, boost exercise capacity
- FDA OKs first human trial of oral MS remyelination therapy PTD802
- Taking high-dose vitamin D daily over the long term helps reduce MS relapses
- Is what I’m feeling a symptom of MS, or is it something else?
- AI analyzes entire gut microbiome to detect MS with high accuracy